Related Experiment Video
Updated: Apr 28, 2026

Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells
Published on: March 9, 2012
Activation of Rheb, but not of mTORC1, impairs spine synapse morphogenesis in tuberous sclerosis complex
Shin Yasuda1, Hiroko Sugiura1, Shutaro Katsurabayashi2
11] Neural Plasticity Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan [2].
Abstract:
Mutations in the Tsc1 or Tsc2 genes cause tuberous sclerosis complex (TSC). Tsc1 and Tsc2 proteins form a complex that inhibits mammalian target of rapamycin complex 1 (mTORC1) signalling through Rheb-GTPase. We found that Tsc2(+/-) neurons showed impaired spine synapse formation, which was resistant to an mTORC1 inhibitor. Knockdown of mTOR also failed to restore these abnormalities, suggesting mTORC may not participate in impaired spinogenesis in Tsc2(+/-) neurons. To address whether Rheb activation impairs spine synapse formation, we expressed active and inactive forms of Rheb in WT and Tsc2(+/-) neurons, respectively. Expression of active Rheb abolished dendritic spine formation in WT neurons, whereas inactive Rheb restored spine synapse formation in Tsc2(+/-) neurons. Moreover, inactivation of Rheb with farnesyl transferase inhibitors recovered spine synapse morphogenesis in Tsc2(+/-) neurons. In conclusion, dendritic spine abnormalities in TSC neurons may be caused through activation of Rheb, but not through of mTORC1.
Insights
Tuberous sclerosis complex (TSC) involves mutations affecting Rheb activation, not mTORC1 signaling, leading to impaired dendritic spine formation in neurons. This finding offers new therapeutic targets for TSC neurological symptoms.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Tuberous sclerosis complex (TSC) results from mutations in Tsc1 or Tsc2 genes.
- The Tsc1/Tsc2 complex normally inhibits mammalian target of rapamycin complex 1 (mTORC1) signaling via Rheb-GTPase.
- Dendritic spine abnormalities are a hallmark of neurological dysfunction in TSC.
Purpose of the Study:
- To investigate the specific molecular mechanisms underlying impaired dendritic spine formation in Tsc2(+/-) neurons.
- To determine the roles of mTORC1 signaling and Rheb activation in TSC-associated spinogenesis defects.
Main Methods:
- Utilized Tsc2(+/-) mouse neurons and wild-type (WT) neurons.
- Administered mTORC1 inhibitors and performed mTOR knockdown.
- Expressed constitutively active and inactive Rheb variants in neurons.
- Applied farnesyl transferase inhibitors to modulate Rheb activity.
Main Results:
- Tsc2(+/-) neurons exhibited impaired dendritic spine formation, unresponsive to mTORC1 inhibition or mTOR knockdown.
- Expression of active Rheb abolished spine formation in WT neurons.
- Inactive Rheb rescued spine formation defects in Tsc2(+/-) neurons.
- Rheb inactivation using farnesyl transferase inhibitors restored dendritic spine morphogenesis in Tsc2(+/-) neurons.
Conclusions:
- Dendritic spine abnormalities in TSC are primarily driven by Rheb activation, not by dysregulation of mTORC1 signaling.
- Targeting Rheb activity presents a potential therapeutic strategy for neurological manifestations of TSC.
Related Concept Videos
TGF - β Signaling Pathway
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
The Ras Gene
Ras is a...
Rab Cascades
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
PI3K/mTOR/AKT Signaling Pathway

